
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇸🇦SA · Science#110500 to 3K
- 🇦🇷AR · Science#119500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
500 to 3K🎙 ~2x weekly·320 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
1K to 6K🇸🇦50%🇦🇷50% - Active Followers
Loyal subscribers who consistently listen
400 to 2.4K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
May 2026 CHEST Journal Editor Highlights
May 1, 2026
18m 50s
Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases
May 1, 2026
13m 20s
Pseudomonas aeruginosa in Patients With Nosocomial Respiratory Infections: A Secondary Analysis of the European Network for ICU-Related Respiratory Infections
May 1, 2026
25m 51s
April 2026 CHEST Journal Editor Highlights
Apr 1, 2026
19m 53s
Use of and Outcomes Related to Intrapleural Enzyme Therapy for Complicated Parapneumonic Effusion and Empyema in an Integrated Health System
Apr 1, 2026
19m 46s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/1/26 | ![]() May 2026 CHEST Journal Editor Highlights | CHEST May 2026, Volume 169, Issue 5 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST May 2026 issue, including an analysis of interactive pathways of key prognostic factors in severe asthma, an investigation of the long-term safety and efficacy of proximal hypoglossal nerve stimulation in OSA, and more. Moderator: Peter Mazzone, MD, MPH, FCCP | 18m 50s | ||||||
| 5/1/26 | ![]() Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases | Valerie Dehondt, PharmD, and Lies Lahousse, PharmD, PhD, join CHEST® Journal Podcast Moderator Gretchen Winter, MD, to discuss their research into the association between long-term proton pump inhibitor use and exacerbation risk in patients with chronic obstructive airway diseases. DOI: 10.1016/j.chest.2026.01.002 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 13m 20s | ||||||
| 5/1/26 | ![]() Pseudomonas aeruginosa in Patients With Nosocomial Respiratory Infections: A Secondary Analysis of the European Network for ICU-Related Respiratory Infections | Luis F. Reyes, MD, PhD, joins CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss his research into the prevalence of Pseudomonas aeruginosa among patients with nosocomial respiratory infections in the ICU. DOI: 10.1016/j.chest.2025.12.033 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 25m 51s | ||||||
| 4/1/26 | ![]() April 2026 CHEST Journal Editor Highlights | CHEST April 2026, Volume 169, Issue 4 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST April 2026 issue, including an exploration of inspiratory effort and dynamic transpulmonary driving pressure in extremely preterm infants undergoing noninvasive ventilation, an investigation of comparative outcomes and side effects of immunosuppressants and tumor necrosis factor inhibitors in sarcoidosis, and more. Moderator: Peter Mazzone, MD, MPH, FCCP | 19m 53s | ||||||
| 4/1/26 | ![]() Use of and Outcomes Related to Intrapleural Enzyme Therapy for Complicated Parapneumonic Effusion and Empyema in an Integrated Health System | Eduardo Solbes, MD, joins CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss his research into the variation in full MIST2 regimen dosing of intrapleural enzyme therapy across 21 hospitals in adults hospitalized with complicated parapneumonic effusion of empyema. DOI: 10.1016/j.chest.2025.11.042 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 19m 46s | ||||||
| 3/2/26 | ![]() March 2026 CHEST Journal Editor Highlights | CHEST March 2026, Volume 169, Issue 3 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST March 2026 issue, including an investigation into a specialist dietary intervention in patients with fibrotic interstitial lung disease experiencing weight loss, an examination of the impact of dual cannabis and tobacco smoking in young patients with lung cancer, and more. Moderator: Peter Mazzone, MD, MPH, FCCP | 18m 26s | ||||||
| 3/2/26 | ![]() Adjunctive Corticosteroid Use and Clinical Outcomes in Non-HIV Pneumocystis jirovecii Pneumonia | Aaron M. Pulsipher, MD, joins CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss his research into the dose-response relationship between adjunctive corticosteroids and outcomes in adult patients with non-HIV Pneumocystis jirovecii pneumonia. DOI: 10.1016/j.chest.2025.10.036 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 22m 46s | ||||||
| 2/16/26 | ![]() CHEST Critical Care: The Impact of Mechanical Power Normalized to Predicted Body Weight on Outcomes in Pediatric ARDS | Authors Herng Lee Tan, MSc, and Judith Ju Ming Wong, MBBCh, BAO, and editorialist Vicent Modesto i Alapont, MD, PhD, join CHEST® Critical Care Podcast Moderator Dan Fein, MD, to discuss their research into the impact of mechanical power normalized to predicted body weight on outcomes in pediatric ARDS. This episode is part of a new series exploring articles published in our open access journal CHEST Critical Care. DOI: 10.1016/j.chstcc.2025.100162 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 34m 42s | ||||||
| 2/2/26 | ![]() February 2026 CHEST Journal Editor Highlights | CHEST February 2026, Volume 169, Issue 2 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2026 issue, including an examination of the association between culture conversion and mortality in patients with Mycobacterium abscessus complex pulmonary disease, an investigation of the comparative effectiveness of tocilizumab vs rituximab in rheumatoid arthritis-associated interstitial lung disease, and more. Moderator: Peter Mazzone, MD, MPH, FCCP | 18m 42s | ||||||
| 2/2/26 | ![]() Comparative Effectiveness of Tocilizumab vs Rituximab in Rheumatoid Arthritis-Associated Interstitial Lung Disease: An Emulated Target Trial | James Cheng Chung Wei, MD, PhD, and Po-Cheng Shih, MD, join CHEST® Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss their research into the comparative effectiveness and safety of tocilizumab and rituximab in patients with rheumatoid arthritis-associated interstitial lung disease. DOI: 10.1016/j.chest.2025.09.009 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 22m 37s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/2/26 | ![]() Intersession Variability in Single-Breath Diffusing Capacity of Carbon Monoxide | Hemang Yadav, MBBS, joins CHEST® Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss his research into the magnitude and determinants of diffusing capacity for carbon monoxide intersession variability in routine clinical practice and evidence-based thresholds that can guide interpretation of serial measurements. DOI: 10.1016/j.chest.2025.09.006 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 35m 18s | ||||||
| 2/2/26 | ![]() Effectiveness of Health Communication Intervention to Improve Knowledge on Timeliness to Return for Annual Lung Cancer Screening: The Larch Trial | Karen J. Wernli, PhD, joins CHEST® Journal Podcast Moderator Gretchen Winter, MD, to discuss her research into additional health communication to improve patient knowledge of lung cancer screening timeliness. DOI: 10.1016/j.chest.2025.07.4111 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number R01CA262015. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. | 20m 47s | ||||||
| 1/28/26 | ![]() Humanities: The Mountain (Episode 4) | Originally aired: January 28, 2026 Avraham Z. Cooper, MD, joins CHEST® Journal Podcast Moderator Abhishek Bhardwaj, MD, to discuss his Exhalations article, “The Mountain,” and explore his relationship with his late father, a physician with a photographic memory, and how his complicated relationship with his father’s legacy has inspired him to become the physician that he is today. This episode is part of a new series exploring articles published in the journal's Humanities section. Moderator: Abhishek Bhardwaj, MD | 39m 20s | ||||||
| 1/5/26 | ![]() January 2026 CHEST Journal Editor Highlights | CHEST January 2026, Volume 169, Issue 1 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST January 2026 issue, including an exploration of intermittent asthma and risk of severe exacerbation in children, an examination of the use of ceftriaxone to prevent early-onset pneumonia in patients following out-of-hospital cardiac arrest, and more. Moderator: Peter Mazzone, MD, MPH, FCCP | 19m 57s | ||||||
| 1/5/26 | ![]() Artificial Intelligence-Based Echocardiography in Pulmonary Arterial Hypertension | Bettia Celestin, MD, and Francois Haddad, MD, join CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss their research into the reliability of a fully automated deep learning workflow in echocardiography when assessing pulmonary hypertension. DOI: 10.1016/j.chest.2025.06.052 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 29m 04s | ||||||
| 12/1/25 | ![]() December 2025 CHEST Journal Editor Highlights | CHEST December 2025, Volume 168, Issue 6 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST December 2025 issue, including an exploration of the relationship between inflammation and mucociliary clearance in chronic respiratory conditions, an investigation into the association of hypoxic burden with major cardiovascular events, and more. Moderator: Peter Mazzone, MD, MPH, FCCP | 18m 25s | ||||||
| 12/1/25 | ![]() The Influence of Hospital Policies on Clinicians’ Decisions to Withhold or Withdraw Life-Sustaining Treatment | Gina M. Piscitello, MD, and Katrina E. Hauschildt, PhD, BCPA, join CHEST® Journal Podcast Moderator Gretchen Winter, MD, to discuss their research into the ways that and extent to which hospital policies influence clinician approaches to decisions to withhold or withdraw life-sustaining treatment among patients admitted to an ICU. DOI: 10.1016/j.chest.2025.06.036 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 21m 09s | ||||||
| 12/1/25 | ![]() The Impact of the Unknown: Patient Experiences With Uncertainty in Sarcoidosis | Kristen R. Mathias, MD, MHS, joins CHEST® Journal Podcast Moderator Gretchen Winter, MD, to discuss her research into the ways patients with sarcoidosis describe their experiences with the disease, how they are impacted by uncertainty around sarcoidosis management, and the challenges they face in receiving care. DOI: 10.1016/j.chest.2025.06.025 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 16m 56s | ||||||
| 11/1/25 | ![]() November 2025 CHEST Journal Editor Highlights | CHEST November 2025, Volume 168, Issue 5 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST November 2025 issue, including an investigation into oxygen saturation targets and neurologic outcomes after cardiac arrest, an exploration of the association of shared decision-making with long-term adherence to lung cancer screening, and more. Moderator: Peter Mazzone, MD, MPH, FCCP | 16m 12s | ||||||
| 11/1/25 | ![]() Low-Tidal-Volume Ventilation and Mortality in Patients With Acute Brain Injury: A Secondary Analysis of an International Observational Study | Shaurya Taran, MD, joins CHEST® Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss his research into the association between low-tidal-volume ventilation and mortality in patients with acute brain injuries receiving mechanical ventilation. DOI: 10.1016/j.chest.2025.06.042 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 24m 53s | ||||||
| 11/1/25 | ![]() Covert Triage During the COVID-19 Pandemic: A Qualitative Analysis of Rationing in Intensive Care | Eva-Maria Schmolke, MD, and Kathrin Knochel, MD, join CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss their research into the institutional implementation of a national triage guideline in German ICUs during the initial phases of the COVID-19 pandemic and their subsequent analysis of widespread covert triage as a response to legal uncertainty around triage guidelines. DOI: 10.1016/j.chest.2025.05.044 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 28m 44s | ||||||
| 11/1/25 | ![]() Longitudinal Pulmonary Arterial Pressure Trajectories Inform Clinical Outcome in Kidney Transplantation Patients | Katarina Zeder, MD, PhD, joins CHEST® Journal Podcast Moderator Matt Siuba, DO, MS, to discuss her research into the ways in which longitudinal pulmonary arterial pressure trajectories inform clinical outcome in patients undergoing kidney transplantation. DOI: 10.1016/j.chest.2025.05.024 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 17m 24s | ||||||
| 11/1/25 | ![]() Oxygen Saturation Targets and Neurologic Outcomes Following Cardiac Arrest: A Secondary Analysis of the Pragmatic Investigation of Optimal Oxygen Targets Trial | Stephanie C. DeMasi, MD, joins CHEST® Journal Podcast Moderator, Matt Siuba, DO, MS, to discuss her research comparing neurologic outcomes between lower and higher oxygen saturation targets following cardiac arrest. DOI: 10.1016/j.chest.2025.04.027 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 14m 26s | ||||||
| 10/1/25 | ![]() October 2025 CHEST Journal Editor Highlights | CHEST October 2025, Volume 168, Issue 4 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST October 2025 issue, including an exploration of the association of physical frailty with incidence and life expectancy of COPD, an investigation of the health and utilization burden of OSA among US active-duty military personnel, and more. Moderator: Peter Mazzone, MD, MPH, FCCP | 15m 52s | ||||||
| 10/1/25 | ![]() The Frequency and Predictors of Pulmonary Rehabilitation Referrals Among Patients With Pulmonary Arterial Hypertension: An Analysis of the Pulmonary Hypertension Association Registry | Morgan Bailey, MD, joins CHEST® Journal Podcast Moderator Gretchen Winter, MD, to discuss her research into the frequency of pulmonary rehabilitation referrals among patients with pulmonary arterial hypertension and the factors associated with underutilization of pulmonary rehabilitation. DOI: 10.1016/j.chest.2025.04.021 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine. | 15m 14s | ||||||
Showing 25 of 320
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.


